GEA Pharma & Healthcare Insight stories

Customer cases

Image of Łódź, Poland

Novel innovation enhances productivity and output for Polish pharma company.

A consultative approach to service, delivery and problem solving ensured that a Polish pharmaceutical company received the equipment and technology it needed to ramp up production and expand into new geographies.

VESTA® valves in state-of-the-art Korean insulin line

GEA has supplied one of the largest drug manufacturers in Korea with manufacturing equipment for a state-of-the-art pharma production plant. More than 7,000 VESTA® sterile valves were installed to direct the product flow in two identical insulin production lines. This was the first time VESTA® valve technology had been selected to completely equip a new greenfield project. The multimillion Euro order represents the biggest project so far in the history of the VESTA® line.

Small-scale batch granulation

Caplin Group and GEA Collaborate to Deliver Contained Oncology Plant in Chennai

Caplin Group partners with GEA, a leading supplier of pharmaceutical containment equipment, to establish a state-of-the-art oncology plant in Chennai. Learn how Caplin's expansion plans and GEA's end-to-end solutions will enhance their production capabilities and deliver high-quality medicines.

Oncogen Pharma

GEA's Landmark Oncology Contract with Oncogen Pharma in Malaysia

Discover GEA's groundbreaking partnership with Oncogen Pharma in Malaysia, as they secure a multi-million Euro contract for the production of oral solid dosage (OSD) forms to treat cancer. Learn how GEA's end-to-end solutions and innovative technologies overcame challenges during the COVID-19 pandemic, ensuring successful project completion and customer satisfaction.

View of the factory of STELLAPHARM

First contained integrated granulation line in Vietnam

GEA’s first contained manufacturing line, including integrated granulation and tablet compression for the production of steroid/hormonal drugs, at STELLAPHARM in Vietnam is approaching completion

GEA supports Pfizer to change from batch-based to continuous manufacturing

GEA supports Pfizer to change from batch-based to continuous manufacturing

With the recent inclusion of a suite of fully automated, highly efficient production equipment to manufacture tablets and capsules, Pfizer’s plant in Freiburg, Germany, has been transformed into what the company calls a “Smart Factory.”

格罗顿(美国康乃迪克州)辉瑞实验室中的 GEA ConsiGma™ 25 设施

基于 POD 的小型工厂让患者更快得到药物

一个由制药企业和供应商组成的合作组织,包括辉瑞、GEA 和 G-CON Manufacturing,欢迎 GSK 加入联盟,该联盟致力于开发按需片剂生产所用的连续技术解决方案。

IBC Blender

Establishing a personal connection proved to be crucial in forging a lasting partnership with a Greek pharmaceutical company.

According to David Hobson, Sales Manager for Materials Handling Technology at GEA Pharma & Healthcare, it all started with a chance encounter at the ACHEMA 2012 trade show.

Penn Pharma Integrated Contained Tableting

Penn Pharma:完全一体化,密闭压片

在进行广泛的市场调研后,Penn Pharma 发现剧毒药品外包研发和生产的固体剂型抗肿瘤药物市场需求有所增加。其生产场所的强效固体剂型产品制造历史已经超过 20 年,但仍需额外的产能。

Consigma 25

基于可用能的批量压片与连续压片评估

在不同的水平实施的“可用能代谢生命周期评估 (ELCA)”有助于在产品或服务的生命周期内使用单一指标确定、定位和量化累计资源消耗模式。

连续压片网页

ConsiGma™ 实例研究:杨森制药

杨森制药的一个团队发起了一项深入的可行性研究,用以评估 ConsiGma™ 技术的性能和限制以及工艺特色。

制药市场 API

喷雾干燥疫苗

GEA 和 Cambridge Biostability Limited (CBL) 开发了一种革命性方法,可使用喷雾干燥来稳定疫苗。

黄色药片

Sprint 项目:连续片剂制造

作为针对药品开发和后续生产研发新一代工艺强化系统战略的一部分,Sprint 项目带给 GEA 一次与关键客户、供应商和学术团体合作的机会。

Consigma 25

连续造粒:实例研究

一家大型制药公司的项目团队发起了一项深入的可行性研究,用以评估 ConsiGma™ 技术的性能和限制以及工艺特色。

连续片剂制造

ConsiGma™ 连续生产技术

为了研究连续生产 (CM) 并优化和加速药品开发过程,Pharmaceuticals, Inc. 联合 GEA 一起增强了现有的技术,并实现了主要的和备份的连续生产工艺。

单罐处理

抗肿瘤药物生产线:卡迪拉公司

当 GEA 向印度客户提供完整的抗肿瘤药物生产线时,他们不仅保证操作人员的健康和安全-符合国际公认标准-,公司也增加了产品收率、降低生产周期时间并实现了高度密闭方案。

接收 GEA 新闻

订阅 GEA 的新闻,掌握 GEA 的创新信息和故事。

联系我们

我们随时为您提供帮助!您只需提供少量详细信息,我们就能回复您的查询。